INTRODUCTION
In the hematopoietic system, aging is driven by both intrinsic and extrinsic factors Dorshkind and Swain, 2009; Geiger et al., 2005; Geiger and Van Zant, 2002; Ju et al., 2007; Morrison et al., 1996; Rando, 2006; Rossi et al., 2005) and manifests as decreased immune response (Linton and Dorshkind, 2004) , increased myelogenous disease (Kiss et al., 2007; Signer et al., 2007) , late-onset anemia (Beghé et al., 2004) , and reduced regenerative capacity (Ergen and Goodell, 2009) . Multiple studies and our own data demonstrate that the aged murine hematopoietic system is impaired in supporting peripheral blood (PB) leukocyte numbers (Figure S1A available online), erythropoiesis (Figures S1B and S1C) , and B-lymphoid and T-lymphoid cells ( Figure S1D ), while the number of myeloid cells is increased ( Figure S1D ). Changes in the total number of primitive hematopoietic cells with age are strain dependent (Kamminga et al., 2005) and are at least in part intrinsic to hematopoietic stem cells (HSCs). For example, in C57BL/6 mice, early hematopoietic progenitor cell (Lineage Figure S1F ). Independent of the strain, aged HSCs show reduced self-renewal activity as determined in serial transplant/engraftment assays (Janzen et al., 2006; Rossi et al., 2005) and exhibit a 2-fold reduced ability to home to the bone marrow (BM) (Liang et al., 2005) . Moreover, aged LSKs are less efficient in their ability to adhere to stroma cells and exhibit significantly elevated cell protrusion activity in vivo (Geiger et al., 2007; Kohler et al., 2009; Xing et al., 2006) . Thus, a defined set of cell-intrinsic phenotypic and functional parameters separate young from aged HSCs. Due to the cellintrinsic component of HSC aging-aged HSCs present with most of these phenotypes also when exposed to a young microenvironment-one refers to young HSCs and aged HSCs when speaking of HSCs from young and aged animals (Geiger and Rudolph, 2009) . Cdc42 belongs to the family of small RhoGTPases and cycles between an active (GTP-bound) and an inactive (GDP-bound) state. Cdc42 is known to regulate actin and tubulin organization, cell-cell and cell-extracellular matrix adhesion, and cell polarity in distinct cell types (Cau and Hall, 2005; Etienne-Manneville, 2004; Florian and Geiger, 2010; Sinha and Yang, 2008) . Our previous and current studies demonstrate that Cdc42 activity is significantly increased in both primitive hematopoietic cells ( Figure S1G ) and other tissues of aged mice when compared with that in cells from young animals (Xing et al., 2006) . Based on this observation we hypothesize that the aging-associated increased Cdc42 activity in HSCs may causatively regulate cell-intrinsic aging of HSCs (Geiger et al., 2007; Kohler et al., 2009) .
RESULTS

Constitutively Increased Cdc42 Activity Results in Aging-like Phenotypes in Young HSCs
To test the role of Cdc42 activity in cell-intrinsic aging of HSCs, we determined whether Cdc42 activity in young HSCs constitutively increased by genetic means is sufficient to resemble aging-like phenotypes in HSCs, using as a model HSCs deficient for the p50RhoGAP protein (Cdc42GAP À/À mice). This RhoGAP protein is a highly selective negative regulator of Cdc42 activity (Barfod et al., 1993) , and therefore Cdc42GAP À/À mice present with a gain of activity specific for Cdc42 in all tissues , including primitive hematopoietic cells (Figures S1I). Supporting our hypothesis, Cdc42GAP À/À mice present with premature aging-like phenotypes in multiple tissues and cell types . As for the hematopoietic system, a significant increase in myeloid cell frequency and a decrease in T cell frequency in PB was detected in young Cdc42GAP À/À mice as well as an overall decrease of B cell frequency and an increase in myeloid cell frequency in BM, which are phenotypes consistent with aging in Figure S1 .
hematopoiesis ( Figure S1J ). To determine the functional status of Cdc42GAP
HSCs, competitive serial transplant assays were performed ( Figure 1A ), which are regarded as a gold standard for determining stem-cell-intrinsic parameters of HSC aging Rossi et al., 2005 Rossi et al., , 2008 . Results demonstrated that young Cdc42GAP
HSCs resemble aged HSCs and were significantly distinct from young control Cdc42GAP +/+ HSCs with respect to their repopulation ability ( Figure 1B ), contribution to the B cell lineage, and contribution to the myeloid cell lineage in PB ( Figures  1C and 1D ) and BM (Figures S1M and S1N) in both primary and secondary recipients. Furthermore, young Cdc42GAP À/À cells, similarly to aged cells, contributed significantly more to the pool of LT-HSCs compared with young Cdc42GAP +/+ controls both in primary and in secondary recipients ( Figures 1E-1G ). There was also a significant decrease in the contribution of aged and Cdc42GAP À/À HSCs to LMPPs in secondary recipients compared with that of young Cdc42GAP +/+ cells ( Figure 1G ). 2008). We recently reported a reduction in the frequency of cells with a polar distribution of microtubules among aged early hematopoietic progenitor cells (LSK cells) (Kohler et al., 2009 ). Cdc42 activity has been implicated in the regulation of polarity in fibroblasts and epithelial cells (Cau and Hall, 2005; Iden and Collard, 2008) and in the maintenance of polarity and stemness in neuronal stem cells (Cappello et al., 2006) . Prompted by these observations we next investigated whether the polarity status of LT-HSCs changes upon aging, and whether Cdc42 activity might be causally involved in regulating such changes. To test this we initially determined the localization of Cdc42, which in itself is a cell polarity marker (Etienne-Manneville, 2004) , and tubulin in LT-HSCs in single-cell immunofluorescence (IF) analyses performed on LT-HSCs. Interestingly, in the majority of young LT-HSCs, Cdc42 and tubulin were asymmetrically distributed and were found at the same location inside the cell (Figures 2A and 2C, Figures S2A and S2C, and Movie S1) . This highly asymmetric localization of Cdc42 and tubulin did not correlate with the side of the cell bound to the substrate or with an uneven distribution of the whole cytoplasm, because, for example, F-actin always showed a cortical and unpolarized distribution (Figures S2E and S2F and Movie S2) . The asymmetry was oriented along the xy plane on one side of the nucleus, where the centrosome was also localized (Figure 2A panels ix-xii and Movie S1). Therefore, in young LT-HSCs, Cdc42 and the microtubules were highly concentrated in the immediate pericentriolar zone and in the cytoplasmatic space along the nucleus/centrosome/cell membrane axis ( Figures 2A and 2D , Movie S1). In contrast, Cdc42 and tubulin were distributed throughout the cell body in an unpolarized fashion in aged Figures S2B, S2D, and S2F, and Movie S3) , and the centrosome was mostly found in the middle of the cell, oriented perpendicularly to the nucleus along the z axis ( Figure 2B panels ix-xi, Figure 2D , and Movie S3). Similar results (young HSCs polar, aged HSCs apolar) were also obtained by analyzing additional established cell polarity markers like Crumbs3 (Figures S2G, S2I, and S2J) and Dgl (Figures S2G and S2K) . Par6 (Figures S2G and S2L) and the aPKCz (Figure S2G) did not follow this pattern, in agreement with recently published data (Sengupta et al., 2011) . Interestingly, the difference in polarity among young and aged primitive hematopoietic cells is specific to LT-HSCs because, for example, we did not observed a difference between young and aged short-term (ST)-HSCs ( Figure S2H ), and it is not correlated to the cycle status, because young and aged LT-HSCs show very similar cell cycle parameter profiles ( Figure S1H and also Rossi et al., 2007; Silva and Conboy, 2008; Sudo et al., 2000) . In summary, chronologically young HSCs present with a polarity phenotype similar to the one previously described for memory T cells (Chang et al., 2007; Ludford-Menting et al., 2005) -which is lost upon aging of LT-HSCs. Recently CD150 expression was described as a marker for functionally distinct subpopulations within the pool of LT-HSCs (Beerman et al., 2010) . The polarity phenotype identifying phenotypically different types of LT-HSCs (polar versus apolar) might thus constitute another surrogate marker for the distinct cell subsets stained by CD150 expression. The frequency of young LTHSCs polarized for Cdc42 and tubulin though was independent of the expression of CD150 on LT-HSCs ( Figures S2M and S2N ).
Consistent with a critical role of elevated Cdc42 activity in ageassociated phenotypes like apolarity, IF staining revealed that the majority of chronologically young Cdc42GAP À/À LT-HSCs, which functionally resemble aged LT-HSCs, were apolar with respect to Cdc42 and tubulin distribution ( Figures 2E and 2F ).
In addition, consistent with our observations comparing chronologically young and aged LT-HSCs ( Figure S1H ), young Cdc42GAP
, Cdc42GAP À/À and aged LT-HSCs present with a similar cell cycle and apoptosis profile (Figures S1K and S1L), strongly implying that differences in polarity are independent of these parameters. These data thus identify Cdc42 as a polarity protein in LT-HSCs showing distinct polarity phenotypes in young and aged LT-HSCs, and support at a role for Cdc42 activity specifically in the regulation of LT-HSC polarity.
Pharmacological Reduction of Cdc42 Activity Rejuvenates Aged LT-HSC Function and Restores the Level and the Spatial Distribution of Histone H4 Lysine 16 Acetylation
Our data imply that the aging-associated increase in Cdc42 activity might be a stem-cell-intrinsic molecular mechanism resulting in both apolarity and impaired function of LT-HSCs with age. We consequently reasoned that inhibiting Cdc42 activity in aged LT-HSCs to the level in young LT-HSCs by pharmacological means might be a possible approach to at least in part revert apolarity as well as the impaired function of aged LT-HSCs. To exclude stem-cell-extrinsic effects and focus on cell-intrinsic mechanisms, LT-HSCs from aged mice were treated in vitro with a selective Cdc42 activity inhibitor (Sakamori et al., 2012) Figures 3C and 3D ). These data demonstrate that elevated Cdc42-GTP levels in aged LT-HSCs cell-intrinsically regulate See also Figure S2 and Movies S1-S3.
both Cdc42 and tubulin distribution and that the apolar distribution of these proteins can be reverted to a polar one by decreasing Cdc42 activity. Thus, CASIN treatment reverted aged LT-HSCs to young HSCs with respect to the polarity phenotype. We next determined whether inhibition of Cdc42 activity in aged LT-HSCs via CASIN treatment could revert at least in part the altered function of aged LT-HSCs to make them become functionally younger. Although CASIN acts transiently on Cdc42 activity, surprisingly, the increase in the percentage of polar cells among aged LT-HSCs induced by CASIN in vitro remained stable for at least up to 6 hr after CASIN withdrawal ( Figures  S3D and S3E ). This result implies a kind of ''polarity memory'' upon transient reduction of Cdc42 activity in aged LT-HSCs, which might allow continuation of the new polar phenotype and the associated function or functions upon transplantation into recipient animals. Therefore, 200 aged LT-HSCs treated with 5mM CASIN overnight were competitively serially transplanted into young recipients and compared to transplants with young and aged untreated LT-HSCs ( Figure 4A ). In primary recipients, overall donor engraftment after 8, 16, and 24 weeks was similar in aged control and aged CASIN-treated LT-HSCs ( Figure 4B ), but remarkably, CASIN treatment of aged LT-HSCs resulted in an increase in contribution to the B cell compartment in PB and a reduced contribution to the myeloid lineage ( Figure 4D ). In addition, CASIN treatment increased the contribution to LSK and common lymphoid progenitor (CLP) populations to a level indistinguishable from that of young LTHSCs ( Figure S4A ). The frequency of donor-derived LT-HSCs among donor-derived LSKs was, as anticipated, doubled in aged control recipients, while upon CASIN treatment this frequency was significantly reduced ( Figure 4F ). In addition, upon secondary transplant, CASIN-treated LT-HSCs presented with an elevated overall regenerative capacity compared with aged LT-HSCs, as indicated by increased and stable chimerism in PB ( Figure 4C ). Moreover, upon secondary transplant, CASINtreated aged LT-HSCs proved to be indistinguishable from young LT-HSCs with respect to B cell and myeloid engraftment in PB and BM ( Figure 4E and Figures S4B and S4C ) and with respect to the contribution to the LT-HSC pool in BM ( Figure 4G ). Young CASIN-treated LT-HSCs that were competitively transplanted in experiments alongside the aged control and aged CASIN-treated LT-HSCs transplants did not show any relevant functional changes compared with young control LT-HSCs (Figures S4D-S4K ), demonstrating that CASIN reverts specifically aging-related phenotypes of aged LT-HSCs.
Because aged HSCs exhibit a 2-fold reduced ability to home to the BM (Dykstra et al., 2011; Liang et al., 2005) and aged early hematopoietic progenitor cells localize more distantly from the endosteum compared with the localization of young cells (Kohler et al., 2009) , we next investigated whether these aging-associated phenotypes were also rejuvenated by CASIN treatment. Homing of young, aged, and aged CASIN-treated LT-HSCs was determined in competitive short-term homing assays (Dykstra et al., 2011) (Figure S5A ), while the distance of LTHSCs from the endosteum was measured by intravital twophoton microscopy (Kohler et al., 2009 ). The data indicate that CASIN-treated aged LT-HSC present with significantly improved homing to the BM and localize closer to the endosteum ( Figures  S5B-S5F ) compared with aged control LT-HSCs.
Finally, the frequency of polar donor-derived LT-HSCs in recipients transplanted with aged, aged CASIN-treated, and young primary LT-HSCs was determined 24 weeks after transplantation. The data indicate that the percentage of donorderived polar LT-HSCs in recipients transplanted with aged 
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CASIN-treated LT-HSCs was similar to the frequency found in young controls, and significantly increased, at least with respect to Cdc42 localization, compared with the frequency found in aged untreated controls ( Figures 4H and 4I) . One explanation for the long-lasting ''memory effect'' on aged LT-HSCs upon transient reduction of Cdc42 activity observed in our experiments might be that reduction of Cdc42 activity to the level seen in young LT-HSCs results in epigenetic marker changes in aged LT-HSCs, accordingly with a proposed role for epigenetic regulation of stem cell aging (Pollina and Brunet, 2011; Rando and Chang, 2012) . Acetylation of histones is a prevalent epigenetic chromatin modification in eukaryotes. Activated Cdc42 was reported to specifically alter acetylation of histone H4 in 3T3 cells (Alberts et al., 1998) , and histone H4 acetylation has been shown to be mitotically stable and inheritable during development (Cavalli and Paro, 1999) . On histone H4, lysine 16 is the most common site of acetylation, and controls chromatin structures as well interactions between nonhistone proteins and chromatin fibers, while it is unique as it is the only lysine residue among N-terminal tails of all histones targeted by the Sir2 (or class III) family of HDACs (Vaquero et al., 2007) . Histone H4 lysine 16 acetylation (AcH4K16) has been implicated in regulating yeast replicative aging (Dang et al., 2009) , and AcH4K16 levels were found to be reduced in multiple tissues of aged mice (Krishnan et al., 2011) .
Consequently, we investigated whether elevated Cdc42 activity might affect histone H4 acetylation levels as well as specifically AcH4K16 patterns in primitive hematopoietic cells including LT-HSCs. Our data demonstrate that young LT-HSCs express higher levels of AcH4K16 than young ST-HSCs and LMPPs do ( Figures 5A and 5D ), in agreement with previous reports (Chung et al., 2009) . Aged LT-HSCs present with an overall decreased level of AcH4K16 compared with young LTHSCs, but still show higher levels of AcH4K16 compared with aged ST-HSCs and LMPPs ( Figures 5A and 5D) . Moreover, aged LT-HSCs only present with two distinct subpopulations expressing low and high AcH4K16 levels ( Figure 5A ), which are not found in young LT-HSCs. Young LT-HSCs are almost exclusively AcH4K16 high cells while 34% of aged LT-HSCs present with a low AcH4K16 expression level. CASIN treatment induces a sharp decrease of the frequency of AcH4K16 low aged LT-HSCs while increasing the frequency of AcH4K16 high cells (Figures 5A-5C ).
This effect of CASIN on AcH4K16 ( Figures 5A-5D ) was specific to LT-HSCs (no effect on ST-HSCs and LMPPs), age specific (young CASIN-treated LT-HSCs did not display any significant modification), and specific to acetylation of lysine 16 on histone H4 (the total level of acetylation on histone H4 was not altered; Figure 5E ). Most interestingly, we observed that AcH4K16 localization within the nucleus of young LT-HSCs was polarized and opposite that of the cytoplasmatic tubulin pole, while the great majority of aged LT-HSCs nuclei were apolar for AcH4K16 localization ( Figures 5F-5H and Movies S4 and S5). Strikingly, CASIN treatment of aged LT-HSCs increased the frequency of aged LT-HSCs with a polar localization of AcH4K16 to a level similar to that found in young LT-HSCs (Figures 5F-5H ). Thus treatment of aged LT-HSCs with CASIN restores the level and the spatial distribution of AcH4K16 to the level seen in young LT-HSCs, consistent with a previous suggested loss of epigenetic regulation in aged HSCs Pollina and Brunet, 2011) . Importantly, our data does not exclude the possibility that inhibition of Cdc42 activity in aged LT-HSCs might also alter additional epigenetic marks like histone methylation patterns. In summary, these data identify elevated Cdc42 activity as a key modulator of a molecular pathway driving intrinsic mechanisms of stem cell aging. Furthermore, these results demonstrate that lowering Cdc42 activity by CASIN treatment rejuvenates aged LT-HSCs with respect to function (lineage skewing, regenerative capacity, and homing) and phenotypic (polarity) and epigenetic (AcH4K16, both level of acetylation and localization within the nucleus) parameters.
DISCUSSION
Until recently, there was a broad consensus that the phenotype of aged HSCs is fixed and dominated by cell-intrinsic regulatory mechanisms that could not be reverted by therapeutic intervention. This paradigm recently started to shift (Rando and Chang, 2012) , because it was demonstrated that impaired contribution to PB upon transplantation of aged HSCs could be ameliorated by either antioxidative therapy or rapamycin treatment (Chen et al., 2009; Ito et al., 2006) . Our data significantly extend these observations as we demonstrate a critical mechanistic role of Cdc42 activity in HSC aging and identify it as a target for pharmacological rejuvenation of stem-cell-intrinsic age-associated phenotypes of LT-HSCs. Also, because the differences in polarity between young and aged LT-HSCs with respect to Cdc42, tubulin, and AcH4K16 are regulated by Cdc42 activity, these data further support a novel concept in which agingassociated changes in LT-HSC self-renewal and differentiation are possibly regulated by changes in stem cell polarity. Our data further identify a role for Cdc42 activity in regulating epigenetic modifications in LT-HSCs and polarity of epigenetic markers (epi-polarity), and identify the loss of this polarity upon aging as a key concept in HSC biology. Interestingly, a recent Figure S5 and Movies S4 and S5.
report described a prominent role for epigenetic modifications in transgenerational and thus long-term-memory-associated longevity in C. elegans (Greer et al., 2011) . Furthermore, genome-wide association studies have recently identified a positive correlation between Cdc42 expression in human white blood cells and increased morbidity and aging (Kerber et al., 2009) were fixed with BD Cytofix Fixation Buffer (BD Biosciences). After fixation cells were gently washed with PBS, permeabilized with 0.2% Triton X-100 (Sigma) in PBS for 20 min, and blocked with 10% Donkey Serum (Sigma) for 30 min. Primary and secondary antibody incubations were performed for 1 hr at room temperature. Coverslips were mounted with ProLong Gold Antifade Reagent with or without DAPI (Invitrogen, Molecular Probes). The cells were coimmunostained with an anti-alpha tubulin antibody (Abcam, rat monoclonal ab6160) detected with an anti-rat AMCA-conjugated secondary antibody or an anti-rat DyLight488-conjugated antibody (Jackson ImmunoResearch), an anti-Cdc42 antibody (Millipore, rabbit polyclonal) or an anti-AcH4K16 antibody (Upstate-Millipore, rabbit polyclonal) detected with an anti-rabbit DyLight549-conjugated antibody (Jackson ImmunoResearch), and/or an anti-Pericentrin-2 antibody (Santa Cruz Biotechnology, goat polyclonal) detected with an anti-goat AMCA-conjugated antibody (Jackson ImmunoResearch). Samples were imaged with an AxioObserver Z1 microscope (Zeiss) equipped with a 633 PH objective. Images were analyzed with AxioVision 4.6 software. Alternatively, samples were analyzed with an LSM710 confocal microscope (Zeiss) equipped with a 633 objective. Primary raw data were imported into the Volocity Software package (Version 6.0, Perkin Elmer) for further processing and conversion into 3D images. As for polarity scoring, the localization of each single-stained protein was considered polarized when a clear asymmetric distribution was visible by drawing a line across the middle of the cell. A total of 50 to 100 LT-HSCs were singularly analyzed per sample. Data are plotted as percentage of the total number of cells scored per sample. Specificity of the anti-Cdc42 antibody in IF was tested on LT-HSCs sorted from mice in which Cdc42 was targeted and deleted specifically in the hematopoietic system (Mx1-Cre;Cdc42 flox/flox mice; Yang et al., 2007) (data not shown).
Competitive Short-Term Homing Assay and Intravital Two-Photon Microscopy For competitive short-term homing assay (Dykstra et al., 2011) , LT-HSCs were sorted from young and aged mice and incubated for 16 hr in HBSS + 10% FBS ± CASIN (5mM) in a water-jacketed incubator at 37 C (5% CO 2 , 3% O 2 ).
After treatment, LT-HSCs were labeled with the cell tracker CFSE (Invitrogen-Molecular probes) or the cell tracker CMRA (Invitrogen-Molecular probes), washed, and mixed, so that 5,000 young + 5,000 aged LT-HSCs or 5,000 aged + 5,000 aged CASIN-treated LT-HSCs could be injected into each lethally irradiated young recipient mouse ( figure S4L ). After 16-18 hr from the stem cell injection, recipient mice were sacrificed and all BM cells were analyzed by flow cytometry so we could quantify relative frequency of CFSE + and CMRA + cells. A total of six recipient mice were injected per experiment (three receiving 5,000 CFSE + young LT-HSCs mixed with 5,000 CMRA + aged LT-HSCs each, and three receiving 5,000 CFSE + aged CASIN-treated LT-HSCs mixed with 5,000 CMRA + aged LT-HSCs each), and the experiment was repeated twice. For intravital two-photon microscopy analysis, LT-HSCs were sorted, treated, labeled, and mixed as aforementioned but injected into nonirradiated recipient young mice. A total of four recipient mice were injected per experiment (two receiving 5,000 CFSE + young LT-HSCs mixed with 5,000 CMRA + aged LT-HSCs each, and two receiving 5,000 CFSE + aged CASIN-treated LT-HSCs mixed with 5,000 CMRA + aged LT-HSCs each). After 16-18 hr from the stem cell injection, recipient mice were prepared for intravital microscopy as previously described (Kohler et al., 2009 ) using isofluran-based intubation narcosis. Briefly, the tibiae were exposed and part of the bone tissue was carefully removed with an electric drill (Dremel) to obtain a very thin (30-50 mm) remaining layer of bone tissue covering the BM cavity. This procedure was permanently controlled by stereomicroscopy. The bone tissue was identified due to its strong autofluorescence (CCD) under unaltered light conditions or using its second-harmonic (SHG) signal (PMT). Animals were kept at 37 C in a PBS water bath while experiments were performed. For imaging, the area was scanned down to $120 mm depth (more than 12 cell layers) using an illumination wavelength of either 800 or 880 nm detecting CFSE (530 nm) and CMRA (580 nm) fluorescence, as well as unaltered light or SHG (at 480 nm emission). Primary raw data were imported into the Volocity Software package (Version 6.0, Perkin Elmer) for further processing and conversion into 3D images and for measurement of the distance between LT-HSCs and the endosteum.
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